CJC-1295 with DAC
Long-acting GHRH analogue
Tetrasubstituted GHRH(1–29) analogue with a C-terminal lysine carrying a maleimidopropionyl Drug Affinity Complex (DAC) that conjugates to serum albumin.
Sold by the box · 1 box = 10 vials · Price shown per box
Buy more, save more
Price per box (10 vials), same size
| 1–4 boxes | $98.00 | — |
| 5–9 boxes | $93.10 | −5% |
| 10+ boxes | $88.20 | −10% |
- Lot-tested. Identity and purity checked by HPLC and mass spectrometry.
- Secure checkout. Your details are encrypted and never sold.
- Free standard shipping on orders over $1,000.
For research use only. Not for human or veterinary use. Not a drug, food, supplement or cosmetic. Sold only to buyers aged 21+.
CJC-1295 with DAC
2 mg · $98.00
Compound profile
Structure & composition
GHRH-receptor agonist (albumin-binding DAC)
- Molecular weight
- 3647.2 g/mol
- Formula
- C165H269N47O46
- Form
- Lyophilized powder
- Purity specification
- ≥99% (HPLC)
Elemental composition
Share of the molecular mass, from the formula C165H269N47O46.
- C54% · 165 atoms
- O20% · 46 atoms
- N18% · 47 atoms
- H7.4% · 269 atoms
CJC-1295 builds on modified GRF(1–29) — GHRH(1–29) amide with the substitutions D-Ala2, Gln8, Ala15 and Leu27 — by adding a lysine-linked maleimidopropionic acid group. The maleimide reacts with the free cysteine of serum albumin, so the peptide circulates as an albumin conjugate in experimental systems. It acts at the GHRH receptor.
Supplied as
Lyophilized powder in sealed glass vials, available in 5 mg. Each lot is analysed for identity and purity against a ≥99% (HPLC) specification. Lot-specific certificates of analysis are listed under Lab results as they are published, and can be requested from our team at any time.
Research use only
For in-vitro laboratory research by qualified professionals. Not a drug, food, dietary supplement or cosmetic, and not for human or veterinary use.
- Compound class
- GHRH-receptor agonist (albumin-binding DAC)
- Molecular formula
- C165H269N47O46
- Molecular weight
- 3647.2 g/mol
- CAS number
- 446262-90-4
- PubChem CID
- 91971820 ↗
- Also known as
- CJC-1295 DAC, DAC:GRF, Drug Affinity Complex GHRH analogue
- Form
- Lyophilized powder
- Purity specification
- ≥99% (HPLC)
- Available sizes
- 2 mg · CJCDAC-2MG5 mg · CJCDAC-5MG10 mg · CJCDAC-10MG
Certificate for the current lot available on request
We publish certificates of analysis here as each lot is released. Need the COA for the lot you’ll receive? Ask us and we’ll send it before you order.
Long-term
Keep lyophilized material at −20 °C, sealed and dry.
Short-term
2–8 °C is suitable for short periods before use.
Protect
Shield from light and moisture; let vials reach room temperature before opening.
Store lyophilized material at −20 °C for long-term storage, or at 2–8 °C for short periods, protected from light and moisture. Allow the sealed vial to reach room temperature before opening to limit condensation. Once reconstituted, keep refrigerated at 2–8 °C and use within the timeframe your protocol allows; avoid repeated freeze–thaw cycles.
Read our storage guideNo reviews yet
Ordered this compound? Share your experience with our documentation, packaging and service.
Related
Related compounds
Peptide Blends
CJC-1295 + Hexarelin Blend
CJC-1295 no DAC (Mod GRF 1-29) · Hexarelin
10 mg
per box (10 vials) · 20 box
Peptide Blends
CJC-1295 + Ipamorelin + GHRP-2 Blend
CJC-1295 no DAC (Mod GRF 1-29) · Ipamorelin · GHRP-2
9 mg
per box (10 vials) · 20 box